• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsBeijing Luzhu Biotechnology
    Picture of Beijing Luzhu Biotechnology logo

    2480 — Beijing Luzhu Biotechnology Share News

    HK$15.400.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    • Market Cap
      HK$3.06bn
    • Enterprise Value
      HK$3.00bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 2480 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    2480 Dividends
    • Brief: Beijing Luzhu Biotechnology Says Recombinant RSV Vaccine Approved For Clinical Trials In China

      12/10/2026 16:30
    • Brief: Beijing Luzhu Biotechnology Posts FY Loss Before Tax Rmb150.4 Million

      18/03/2026 15:28
    • Brief: Beijing Luzhu Biotechnology Enters Facility Agreements With Commercial Banks For RMB570.0 Mln

      12/12/2024 10:35
    • Brief: Beijing Luzhu Biotechnology Says It Repurchased Total 1.4 Mln H Shares

      15/07/2024 12:09
    • Brief: Beijing Luzhu Biotechnology Says Applied For Approval Of Listing Of 59.7 Million H Shares

      29/01/2024 15:30
    • Brief: Beijing Luzhu Biotechnology Says Got Filing Notice Issued By CSRC

      17/01/2024 13:54
    • Brief: Beijing Luzhu Biotechnology Says Hebei Construction To Provide Construction Services For RMB75.2 Mln

      30/08/2023 13:17
    • Brief: Beijing Luzhu Biotechnology Says HY Loss RMB79.4 Mln

      21/08/2023 11:24
    • Brief: Beijing Luzhu Biotechnology Sees Net Loss Of Not More Than RMB80 Mln For HY

      09/08/2023 12:04
    • Brief: Beijing Luzhu Biotechnology Says Zhang Hui Tendered Resignation As Chief Financial Officer

      14/06/2023 12:29
    • Beijing Luzhu jumps over 13% as vaccine candidate moves to phase III trial

      31/05/2023 05:29

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.